glp 1 receptor drugs Frontiers Glucagon-like peptide-1 receptor: mechanisms and

Consequently, governments, payers, and employers are beginning to adopt these agents as core components of preventive and chronic disease management strategies, driving exponential market demand

With the dual effect of "diabetes" and "weight loss", the development of GLP-1 long-acting receptor agonists has become a research hotspot at home and abroad

Sci Transl Med 9(404):eaan0972 Mitchell JL et al (2023) The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial

GLP-1 and GIP are incretin hormones secreted by intestinal epithelial cells following food intake

[DOI] [PubMed] [Google Scholar] 50.Grossman D.C., Bibbins-Domingo K., Curry S.J., Barry M.J., Davidson K.W., Doubeni C.A., Epling J.W., Kemper A.R., Krist A.H., Kurth A.E., et al